PD-1 blockade increased atherosclerotic lesion inflammation in hypercholesterolemic Ldlr−/− mice, suggesting that PD-1 acts as negative regulator of inflammation in atherosclerosis [29]. This evidence concerns the gene PDCD1 and atherosclerosis.